{"id":32839,"date":"2024-12-03T15:27:03","date_gmt":"2024-12-03T22:27:03","guid":{"rendered":"https:\/\/periodicorealidades.com\/?p=32839"},"modified":"2024-12-03T15:27:03","modified_gmt":"2024-12-03T22:27:03","slug":"cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer","status":"publish","type":"post","link":"https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/","title":{"rendered":"Cofepris autoriza tratamiento biotecnol\u00f3gico para tratar el alzh\u00e9imer"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Aproximadamente un mill\u00f3n 300 mil personas padecen alzh\u00e9imer en M\u00e9xico; esta cifra representa entre 60 y 70 por ciento de los diagn\u00f3sticos de demencia.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris) aprob\u00f3 un&nbsp;<strong>tratamiento para combatir el alzh\u00e9imer,<\/strong>&nbsp;una enfermedad que afecta a m\u00e1s de 1.3 millones de personas en M\u00e9xico, seg\u00fan datos de la Secretar\u00eda de Salud.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El pasado 26 de noviembre, la Comisi\u00f3n aprob\u00f3 el registro sanitario de&nbsp;<strong>lecanemab,<\/strong>&nbsp;un medicamento biotecnol\u00f3gico innovador para el tratamiento del alzh\u00e9imer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cEste medicamento, est\u00e1 indicado para pacientes diagnosticados en&nbsp;<strong>etapa temprana de la enfermedad<\/strong>, en la cual pueden desenvolverse de manera independiente, pero manifiestan episodios de p\u00e9rdida de memoria, como olvidar palabras familiares o la ubicaci\u00f3n de objetos cotidianos\u201d, asever\u00f3.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Las personas con alzh\u00e9imer tienden a experimentar<strong>&nbsp;dificultades con la memoria reciente<\/strong>, acompa\u00f1adas de problemas de lenguaje, confusi\u00f3n en el pensamiento abstracto y desorientaci\u00f3n. Adem\u00e1s, suelen mostrar cambios en el estado de \u00e1nimo y perder habilidades que antes dominaban, como conducir, reconocer lugares familiares o recordar los nombres de personas cercanas. Tambi\u00e9n pueden enfrentar retos en tareas cotidianas, como vestirse sin ayuda, entre otros signos caracter\u00edsticos de la enfermedad.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cEn fases terminales es posible que quienes sufren este padecimiento presenten<strong>&nbsp;dificultades al ingerir alimentos, caminar, hablar,<\/strong>&nbsp;as\u00ed como de incontinencia fecal y urinaria\u201d, asever\u00f3.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Aproximadamente un<strong>&nbsp;mill\u00f3n 300 mil personas padecen alzh\u00e9imer en M\u00e9xico;&nbsp;<\/strong>esta cifra representa entre 60 y 70 por ciento de los diagn\u00f3sticos de demencia y con mayor frecuencia afecta a personas mayores de 65 a\u00f1os. En el mundo, seg\u00fan cifras de la Organizaci\u00f3n Mundial de la Salud (OMS) cerca de 60 millones de personas viven con esta enfermedad.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cAl garantizar el acceso a medicamentos innovadores, Cofepris reafirma su compromiso con la autorizaci\u00f3n de tratamientos que contribuyen a brindar una\u00a0<strong>atenci\u00f3n adecuada a pacientes con alzh\u00e9imer<\/strong>\u00a0y mejorar su calidad de vida\u201d, sostuvo la Cofepris.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aproximadamente un mill\u00f3n 300 mil personas padecen alzh\u00e9imer en M\u00e9xico; esta cifra representa entre 60 y 70 por ciento de los diagn\u00f3sticos de demencia. La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris) aprob\u00f3 un&nbsp;tratamiento para combatir el alzh\u00e9imer,&nbsp;una enfermedad que afecta a m\u00e1s de 1.3 millones de personas en M\u00e9xico, seg\u00fan datos de [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-32839","post","type-post","status-publish","format-standard","category-salud"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cofepris autoriza tratamiento biotecnol\u00f3gico para tratar el alzh\u00e9imer - Peri\u00f3dico Realidades<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cofepris autoriza tratamiento biotecnol\u00f3gico para tratar el alzh\u00e9imer - Peri\u00f3dico Realidades\" \/>\n<meta property=\"og:description\" content=\"Aproximadamente un mill\u00f3n 300 mil personas padecen alzh\u00e9imer en M\u00e9xico; esta cifra representa entre 60 y 70 por ciento de los diagn\u00f3sticos de demencia. La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris) aprob\u00f3 un&nbsp;tratamiento para combatir el alzh\u00e9imer,&nbsp;una enfermedad que afecta a m\u00e1s de 1.3 millones de personas en M\u00e9xico, seg\u00fan datos de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/\" \/>\n<meta property=\"og:site_name\" content=\"Peri\u00f3dico Realidades\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/periodicorealidades.denayarit?mibextid=LQQJ4d\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-03T22:27:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/periodicorealidades.com\/wp-content\/uploads\/2024\/12\/alzheimer-gen-descubren-2-23012024.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"750\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Arcelia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arcelia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/index.php\\\/2024\\\/12\\\/03\\\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/index.php\\\/2024\\\/12\\\/03\\\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\\\/\"},\"author\":{\"name\":\"Arcelia\",\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/#\\\/schema\\\/person\\\/ed60e33c6767be45db655d22ad0c15c4\"},\"headline\":\"Cofepris autoriza tratamiento biotecnol\u00f3gico para tratar el alzh\u00e9imer\",\"datePublished\":\"2024-12-03T22:27:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/index.php\\\/2024\\\/12\\\/03\\\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\\\/\"},\"wordCount\":353,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/#organization\"},\"articleSection\":[\"Salud\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/periodicorealidades.com\\\/index.php\\\/2024\\\/12\\\/03\\\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/index.php\\\/2024\\\/12\\\/03\\\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\\\/\",\"url\":\"https:\\\/\\\/periodicorealidades.com\\\/index.php\\\/2024\\\/12\\\/03\\\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\\\/\",\"name\":\"Cofepris autoriza tratamiento biotecnol\u00f3gico para tratar el alzh\u00e9imer - Peri\u00f3dico Realidades\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/#website\"},\"datePublished\":\"2024-12-03T22:27:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/index.php\\\/2024\\\/12\\\/03\\\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/periodicorealidades.com\\\/index.php\\\/2024\\\/12\\\/03\\\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/index.php\\\/2024\\\/12\\\/03\\\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/periodicorealidades.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cofepris autoriza tratamiento biotecnol\u00f3gico para tratar el alzh\u00e9imer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/#website\",\"url\":\"https:\\\/\\\/periodicorealidades.com\\\/\",\"name\":\"Peri\u00f3dico Realidades\",\"description\":\"M\u00e9dio de comunicaci\u00f3n en Nayarit\",\"publisher\":{\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/periodicorealidades.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/#organization\",\"name\":\"Peri\u00f3dico Realidades\",\"url\":\"https:\\\/\\\/periodicorealidades.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/periodicorealidades.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/r-prueba.png\",\"contentUrl\":\"https:\\\/\\\/periodicorealidades.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/r-prueba.png\",\"width\":709,\"height\":709,\"caption\":\"Peri\u00f3dico Realidades\"},\"image\":{\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/periodicorealidades.denayarit?mibextid=LQQJ4d\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/periodicorealidades.com\\\/#\\\/schema\\\/person\\\/ed60e33c6767be45db655d22ad0c15c4\",\"name\":\"Arcelia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/36cdbbe591db4ecc4985aac5ab27b8093cf6488d3b664974f0cda2e38368b10d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/36cdbbe591db4ecc4985aac5ab27b8093cf6488d3b664974f0cda2e38368b10d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/36cdbbe591db4ecc4985aac5ab27b8093cf6488d3b664974f0cda2e38368b10d?s=96&d=mm&r=g\",\"caption\":\"Arcelia\"},\"url\":\"https:\\\/\\\/periodicorealidades.com\\\/index.php\\\/author\\\/editor-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cofepris autoriza tratamiento biotecnol\u00f3gico para tratar el alzh\u00e9imer - Peri\u00f3dico Realidades","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/","og_locale":"es_MX","og_type":"article","og_title":"Cofepris autoriza tratamiento biotecnol\u00f3gico para tratar el alzh\u00e9imer - Peri\u00f3dico Realidades","og_description":"Aproximadamente un mill\u00f3n 300 mil personas padecen alzh\u00e9imer en M\u00e9xico; esta cifra representa entre 60 y 70 por ciento de los diagn\u00f3sticos de demencia. La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris) aprob\u00f3 un&nbsp;tratamiento para combatir el alzh\u00e9imer,&nbsp;una enfermedad que afecta a m\u00e1s de 1.3 millones de personas en M\u00e9xico, seg\u00fan datos de [&hellip;]","og_url":"https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/","og_site_name":"Peri\u00f3dico Realidades","article_publisher":"https:\/\/www.facebook.com\/periodicorealidades.denayarit?mibextid=LQQJ4d","article_published_time":"2024-12-03T22:27:03+00:00","og_image":[{"width":1200,"height":750,"url":"https:\/\/periodicorealidades.com\/wp-content\/uploads\/2024\/12\/alzheimer-gen-descubren-2-23012024.jpeg","type":"image\/jpeg"}],"author":"Arcelia","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Arcelia","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/#article","isPartOf":{"@id":"https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/"},"author":{"name":"Arcelia","@id":"https:\/\/periodicorealidades.com\/#\/schema\/person\/ed60e33c6767be45db655d22ad0c15c4"},"headline":"Cofepris autoriza tratamiento biotecnol\u00f3gico para tratar el alzh\u00e9imer","datePublished":"2024-12-03T22:27:03+00:00","mainEntityOfPage":{"@id":"https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/"},"wordCount":353,"commentCount":0,"publisher":{"@id":"https:\/\/periodicorealidades.com\/#organization"},"articleSection":["Salud"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/","url":"https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/","name":"Cofepris autoriza tratamiento biotecnol\u00f3gico para tratar el alzh\u00e9imer - Peri\u00f3dico Realidades","isPartOf":{"@id":"https:\/\/periodicorealidades.com\/#website"},"datePublished":"2024-12-03T22:27:03+00:00","breadcrumb":{"@id":"https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/periodicorealidades.com\/index.php\/2024\/12\/03\/cofepris-autoriza-tratamiento-biotecnologico-para-tratar-el-alzheimer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/periodicorealidades.com\/"},{"@type":"ListItem","position":2,"name":"Cofepris autoriza tratamiento biotecnol\u00f3gico para tratar el alzh\u00e9imer"}]},{"@type":"WebSite","@id":"https:\/\/periodicorealidades.com\/#website","url":"https:\/\/periodicorealidades.com\/","name":"Peri\u00f3dico Realidades","description":"M\u00e9dio de comunicaci\u00f3n en Nayarit","publisher":{"@id":"https:\/\/periodicorealidades.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/periodicorealidades.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/periodicorealidades.com\/#organization","name":"Peri\u00f3dico Realidades","url":"https:\/\/periodicorealidades.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/periodicorealidades.com\/#\/schema\/logo\/image\/","url":"https:\/\/periodicorealidades.com\/wp-content\/uploads\/2023\/05\/r-prueba.png","contentUrl":"https:\/\/periodicorealidades.com\/wp-content\/uploads\/2023\/05\/r-prueba.png","width":709,"height":709,"caption":"Peri\u00f3dico Realidades"},"image":{"@id":"https:\/\/periodicorealidades.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/periodicorealidades.denayarit?mibextid=LQQJ4d"]},{"@type":"Person","@id":"https:\/\/periodicorealidades.com\/#\/schema\/person\/ed60e33c6767be45db655d22ad0c15c4","name":"Arcelia","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/36cdbbe591db4ecc4985aac5ab27b8093cf6488d3b664974f0cda2e38368b10d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/36cdbbe591db4ecc4985aac5ab27b8093cf6488d3b664974f0cda2e38368b10d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/36cdbbe591db4ecc4985aac5ab27b8093cf6488d3b664974f0cda2e38368b10d?s=96&d=mm&r=g","caption":"Arcelia"},"url":"https:\/\/periodicorealidades.com\/index.php\/author\/editor-2\/"}]}},"_links":{"self":[{"href":"https:\/\/periodicorealidades.com\/index.php\/wp-json\/wp\/v2\/posts\/32839","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/periodicorealidades.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/periodicorealidades.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/periodicorealidades.com\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/periodicorealidades.com\/index.php\/wp-json\/wp\/v2\/comments?post=32839"}],"version-history":[{"count":0,"href":"https:\/\/periodicorealidades.com\/index.php\/wp-json\/wp\/v2\/posts\/32839\/revisions"}],"wp:attachment":[{"href":"https:\/\/periodicorealidades.com\/index.php\/wp-json\/wp\/v2\/media?parent=32839"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/periodicorealidades.com\/index.php\/wp-json\/wp\/v2\/categories?post=32839"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/periodicorealidades.com\/index.php\/wp-json\/wp\/v2\/tags?post=32839"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}